Study of Predictors of Failure of Sulprostone Treatment in Postpartum Hemorrhage

University Hospital, Strasbourg, France300 enrolled

Overview

The investigators wish to identify potential factors predicting failure of second-line drug treatment (sulproston (Nalador®)): risk factors and factors linked to a failure to take initial care for PPH. A better understanding of the aggravating factors of HPP and more particularly the factors inherent to the initial care would make it possible to think of ways to improve practices.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Postpartum Hemorrhage

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Major subject (≥18 years old) * Subject having given birth at HUS or CHU Poissy Saint-Germain-en Laye between 01/01/2019 and 31/12/2020 * Subject having presented a postpartum haemorrhage treated with Sulprostone * Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research Exclusion Criteria: * Subject having expressed opposition to participating in the study * Subject under guardianship or guardianship * Subject under safeguard of justice

Locations (1)

École de sages-femmes de Strasbourg

Strasbourg, Starsbourg, France

Outcomes

Primary Outcomes

This a rétrospective study trayning to identify a potential predictors of failure of second-line drug treatment in the case of severe postpartum hemorrhage

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.